|
|
|
51-200 employees
View all
|
|
biotechnology
|
|
12400 High Bluff Dr.,San Diego,CA,US
|
|
Evofem Biosciences, Inc., (NASDAQ: EVFM) is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The Company’s first commercial product, Phexxi™ (lactic acid, citric acid and potassium bitartrate), is the first and only vaginal pH regulator approved in the United States for the prevention of pregnancy. The Company is also advancing EVO100 into Phase 3 clinical trials for the prevention of urogenital transmission of both Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women.
|
Evofem Biosciences Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
66.67%
|
The widely used Evofem Biosciences email format is {f}{last} (e.g. [email protected]) with 66.67% adoption across the company.
To contact Evofem Biosciences customer service number in your country click here to find.
Saundra Pelletier is the CEO of Evofem Biosciences. To contact Saundra Pelletier email at [email protected] or [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.